B. Mehlis

581 total citations
34 papers, 485 citations indexed

About

B. Mehlis is a scholar working on Molecular Biology, Reproductive Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, B. Mehlis has authored 34 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Reproductive Medicine and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in B. Mehlis's work include Chemical Synthesis and Analysis (12 papers), Hypothalamic control of reproductive hormones (8 papers) and Analytical Chemistry and Chromatography (5 papers). B. Mehlis is often cited by papers focused on Chemical Synthesis and Analysis (12 papers), Hypothalamic control of reproductive hormones (8 papers) and Analytical Chemistry and Chromatography (5 papers). B. Mehlis collaborates with scholars based in Germany, United States and Czechia. B. Mehlis's co-authors include Michael Bienert, Hartmut Niedrich, Klaus Fechner, P Oehme, J. Bergmann, H. Berger, Klaus Gast, Dietrich Zirwer, G. Rafler and Manfred Becker and has published in prestigious journals such as Analytical Biochemistry, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

B. Mehlis

32 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Mehlis Germany 14 251 132 74 59 58 34 485
P. M. Hardy United Kingdom 12 418 1.7× 185 1.4× 64 0.9× 40 0.7× 190 3.3× 21 793
T Wheatley United States 13 167 0.7× 77 0.6× 29 0.4× 30 0.5× 35 0.6× 18 679
Kathrin Bellmann‐Sickert Germany 16 608 2.4× 205 1.6× 22 0.3× 86 1.5× 122 2.1× 30 920
Patrick Hubert France 9 166 0.7× 24 0.2× 46 0.6× 25 0.4× 52 0.9× 18 372
Pascal Delmas France 9 296 1.2× 66 0.5× 27 0.4× 168 2.8× 76 1.3× 11 571
Osamu Hosoya Japan 14 263 1.0× 86 0.7× 15 0.2× 26 0.4× 34 0.6× 48 523
Gail K. Mattson United States 15 291 1.2× 143 1.1× 30 0.4× 36 0.6× 203 3.5× 24 601
Raik Wolf Germany 14 145 0.6× 135 1.0× 43 0.6× 10 0.2× 80 1.4× 20 431
DeAnne Stolarik United States 14 250 1.0× 29 0.2× 39 0.5× 23 0.4× 93 1.6× 20 730
Hidetomo Yokoo Japan 16 515 2.1× 186 1.4× 22 0.3× 30 0.5× 89 1.5× 67 771

Countries citing papers authored by B. Mehlis

Since Specialization
Citations

This map shows the geographic impact of B. Mehlis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Mehlis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Mehlis more than expected).

Fields of papers citing papers by B. Mehlis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Mehlis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Mehlis. The network helps show where B. Mehlis may publish in the future.

Co-authorship network of co-authors of B. Mehlis

This figure shows the co-authorship network connecting the top 25 collaborators of B. Mehlis. A scholar is included among the top collaborators of B. Mehlis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Mehlis. B. Mehlis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beyermann, Michael, Eberhard Krause, Jens Furkert, et al.. (1998). The Degradation of Corticotropin-releasing Factor by Enzymes of the Rat Brain Studied by Liquid Chromatography–Mass Spectrometry. Peptides. 19(4). 649–658. 9 indexed citations
2.
Furkert, Jens, et al.. (1997). Identification and measurement of β-endorphin levels in the skin during induced hair growth in mice. Biochimica et Biophysica Acta (BBA) - General Subjects. 1336(2). 315–322. 26 indexed citations
3.
Schröder, Detlef, et al.. (1995). Liquid chromatographic-mass spectrometric studies on the enzymatic degradation of β-endorphin by endothelial cells. Journal of Chromatography A. 712(1). 169–175. 7 indexed citations
4.
Mehlis, B., et al.. (1995). Pathways of degradation of buserelin by rat kidney membrane.. Journal of Pharmacology and Experimental Therapeutics. 273(2). 709–715. 10 indexed citations
5.
Berger, H., et al.. (1994). Liquid chromatographic-mass spectrometric studies on the enzymatic degradation of gonadotropin-releasing hormone. Journal of Chromatography A. 661(1-2). 55–60. 21 indexed citations
6.
Bienert, Michael, et al.. (1993). Spontaneous chemical degradation of substance P in the solid phase and in solution. International journal of peptide & protein research. 41(3). 207–211. 32 indexed citations
7.
Berger, Hartmut, et al.. (1991). Gonadotropin-releasing hormone (GnRH) analogs: relationship between their structure, proteolytic inactivation and pharmacokinetics in rats. Regulatory Peptides. 33(3). 299–311. 15 indexed citations
8.
Dathe, Margitta, Klaus Gast, Dietrich Zirwer, Heinz Welfle, & B. Mehlis. (1990). Insulin aggregation in solution. International journal of peptide & protein research. 36(4). 344–349. 42 indexed citations
9.
Rafler, G., et al.. (1990). Synthesis and properties of biodegradable aliphatic polyesters. British Polymer Journal. 23(3). 235–240. 43 indexed citations
10.
Berger, H., et al.. (1988). Gonadotropin-releasing hormone (GnRH) pharmacokinetics: Peptide hormone pharmacokinetics needs clarification. Life Sciences. 42(9). 985–991. 7 indexed citations
11.
Berger, Hartmut, et al.. (1988). Proteolytic inactivation of luteinizing hormone-releasing hormone (LHRH) by the whole rat ovary in vitro. Peptides. 9(1). 7–12. 9 indexed citations
12.
Dautzenberg, H., F. Loth, Klaus Fechner, B. Mehlis, & K. Pommerening. (1985). Preparation and performance of symplex capsules. Die Makromolekulare Chemie. 9(S19851). 203–210. 30 indexed citations
13.
Berger, Hartmut, Károly Nikolics, Balázs Szőke, & B. Mehlis. (1983). Proteolytic degradation of gonadotropin-releasing hormone (GnRH) by rat ovarian fractions in vitro. Peptides. 4(6). 821–825. 7 indexed citations
14.
Mehlis, B., et al.. (1980). CIRCULAR DICHROISM STUDIES OF SUBSTANCE P AND ITS C‐TERMINAL SEQUENCES. International journal of peptide & protein research. 15(1). 20–28. 34 indexed citations
15.
Bienert, Michael, et al.. (1979). Synthese von Substanz P und acylierten Teilsequenzen. Journal für praktische Chemie. 321(5). 721–740. 16 indexed citations
16.
Mehlis, B., et al.. (1979). Darstellung von Dansyl‐glycin‐N‐hydroxysuccinimidester ‐ Reagens zur selektiven Einführung des Dansyl‐Fluorophors. Zeitschrift für Chemie. 19(12). 455–456. 1 indexed citations
17.
Bienert, Michael, et al.. (1978). Synthese von Halogenacetyl‐ und Chlorambucil‐Peptiden des Eledoisins, Physalaemins und der Substanz P als potentielle Affinitätsmarker. Journal für praktische Chemie. 320(2). 261–269. 2 indexed citations
18.
Niedrich, Hartmut, Michael Bienert, B. Mehlis, J. Bergmann, & P Oehme. (1975). [Studies on the mechanism of action of peptides attacking smooth muscles. III. The effect of N-azylation on the activity of C-terminal partial sequences of eledoisin, physalaemin and substance P on the guinea pig ileum].. PubMed. 34(3). 483–9. 1 indexed citations
19.
Bergmann, J., Michael Bienert, Hartmut Niedrich, B. Mehlis, & P Oehme. (1974). Über den Einfluss der Kettenlänge bei C-terminalen Sequenzen der Substanz P — in Vergleich mit analogen Physalaemin- und Eledoisin-Peptiden—auf die Wirksamkeit am Meerschweinchen-Ileum. Cellular and Molecular Life Sciences. 30(4). 401–403. 45 indexed citations
20.
Mehlis, B., et al.. (1971). Ein fluoreszenzmarkiertes Physalaemin-Analoges mit hoher biologischer Aktivität. Cellular and Molecular Life Sciences. 27(8). 930–931. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026